​

Onconetix (ONCO) Revenue & Revenue Breakdown

OverviewFinancialsChart

Onconetix Revenue Highlights

Latest Revenue (Y)

$815.37K

Latest Revenue (Q)

$106.49K

Main Segment (Y)

License

Main Geography (Y)

European Union

Onconetix Revenue by Period

Onconetix Revenue by Year

DateRevenueChange
2025-12-31$815.37K-67.70%
2024-12-31$2.52M4217.31%
2023-12-31$58.47K100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Onconetix generated $815.37K in revenue during NA 2025, up -67.70% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Onconetix Revenue by Quarter

DateRevenueChange
2025-06-30$106.49K4.79%
2025-03-31$101.63K-85.73%
2024-12-31$711.98K74.99%
2024-09-30$406.86K-42.28%
2024-06-30$704.85K0.63%
2024-03-31$700.43K1098.04%
2023-12-31$58.47K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-03-31--

Onconetix generated $106.49K in revenue during Q2 2025, up 4.79% compared to the previous quarter, and up 15.20% compared to the same period a year ago.

Onconetix Revenue Breakdown

Onconetix Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25
License$0.60

Onconetix's latest annual revenue breakdown by segment (product or service), as of Dec 25: License (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 25Sep 24Jun 24Mar 24
Product$100.00K$100.00K$100.00K$100.00K

Onconetix's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (100.00%).

Onconetix Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24Dec 23
European Union$796.59K$2.44M-
UNITED STATES-$63.12K-
SWITZERLAND--$58.47K

Onconetix's latest annual revenue breakdown by geography, as of Dec 25: European Union (100.00%).

Quarterly Revenue by Country

CountryDec 25Jun 25Mar 25
European Union$597.99K$104.21K$94.38K

Onconetix's latest quarterly revenue breakdown by geography, as of Dec 25: European Union (100.00%).

Onconetix Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SPRCSciSparc$2.88M$907.00K
ONCOOnconetix$815.37K$106.49K
SCNIScinai Immunotherapeutics--
INDPIndaptus Therapeutics--
REVBRevelation Biosciences--
ENVBEnveric Biosciences--
JSPRJasper Therapeutics--
PTIXProtagenic Therapeutics--
SLXNSilexion Therapeutics--

ONCO Revenue FAQ

What is Onconetix’s yearly revenue?

Onconetix's yearly revenue for 2025 was $815.37K, representing a decrease of -67.70% compared to 2024. The company's yearly revenue for 2024 was $2.52M, representing an increase of 4217.31% compared to 2023. ONCO's yearly revenue for 2023 was $58.46K, representing an increase of 100.00% compared to 2022.

What is Onconetix’s quarterly revenue?

Onconetix's quarterly revenue for Q2 2025 was $106.49K, a 4.79% increase from the previous quarter (Q1 2025), and a -84.89% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $101.63K, a -85.73% decrease from the previous quarter (Q4 2024), and a -85.49% decrease year-over-year (Q1 2024). ONCO's quarterly revenue for Q4 2024 was $711.98K, a 74.99% increase from the previous quarter (Q3 2024), and a 1117.78% increase year-over-year (Q4 2023).

What is Onconetix’s revenue growth rate?

Onconetix's revenue growth rate for the last 3 years (2023-2025) was 1294.63%, and for the last 5 years (2021-2025) was 0%.

What are Onconetix’s revenue streams?

Onconetix's revenue streams in c 25 are License

What is Onconetix’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Onconetix was License. This segment made a revenue of $0.6, representing 100.00% of the company's total revenue.